FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ketamine Injection
Status: Currently in Shortage
»Date first posted: 02/16/2018
»Therapeutic Categories: Anesthesia

Expand all

Hospira, Inc. (Reverified 12/06/2018)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg/5 mL (100 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2051-05) Next Delivery and Estimated Recovery: December 2019 Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter

Other
500 mg/10 mL (50 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2053-10) Next Delivery: March 2020; Estimated Recovery: June 2020 Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter

Other

Mylan Institutional (Reverified 12/07/2018)

Company Contact Information:
800-RXMYLAN (1-800-796- 9526)

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200 mg / 20 mL (NDC 67457-181-20) Intermittent supply until Q1 2019 Demand increase for the drug
500 mg / 10 mL (NDC 67457-001-10) Intermittent supply until Q1 2019 Demand increase for the drug
1000 mg / 10 mL (NDC 67457-108-10) Intermittent supply until Q1 2019 Demand increase for the drug

Par Pharmaceutical (Revised 07/18/2018)

Company Contact Information:
201-802-4000

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg/mL, 20 mL MDV (NDC 42023-113-10) Releasing inventory on a monthly basis. Intermittent supply is available through the end of 2018. Demand increase for the drug
100 mg/mL, 5 mL MDV (NDC 42023-115-10) Releasing inventory on a monthly basis. Intermittent supply is available through the end of 2018. Demand increase for the drug
50 mg/mL, 10 mL MDV (NDC 42023-114-10) Releasing inventory on a monthly basis. Intermittent supply is available through the end of 2018. Demand increase for the drug

West-Ward Pharmaceuticals (Revised 10/03/2018)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg/mL, 10 mL vial (NDC 0143-9508-10) This presentation is temporarily on backorder. Additional lots are scheduled to be manufactured and available in the October 2018 timeframe. Product will be made available as it is released. Demand increase for the drug
100 mg/mL, 5 mL vial (NDC 0143-9509-10) Temporarily on backorder. Additional lots are scheduled to be manufactured and available in the October/November 2018 timeframe. Product will be made available as it is released. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English